R. Carter Pate

This profile gathers the share dealings of R. Carter Pate across 3 companies, led by Option Care Health, Inc., Purple Innovation, Inc. and Teligent, Inc. In total, 19 filings cover trades dated from 10 May 2021 to 27 February 2026.

Both buying and selling appear: 5 purchases worth €135k, against 6 sales worth €1.2M. The net balance comes to €1.1M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 6 share grants. 2026 to date brings no purchases and 1 sale.

In size, the median ticket on the buying side is €18k. 3 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 3 March 2026 came the latest disclosure, an open-market sale for €822k in Option Care Health, Inc. The clock since the last published purchase (21 August 2025) now reads 423 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.